161 related articles for article (PubMed ID: 11925872)
1. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
Shindo T; Yumoto Y; Yoshida M; Okuda T
Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
[TBL] [Abstract][Full Text] [Related]
2. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
[TBL] [Abstract][Full Text] [Related]
3. Effective cytotoxic treatment of primary plasma cell leukaemia--a report of 3 cases.
Gangadharan VP; Satishkumar K; Pillai R; Cherian V
Acta Oncol; 1994; 33(6):714-5. PubMed ID: 7946458
[No Abstract] [Full Text] [Related]
4. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
5. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.
Yamagata N; Shimazaki C; Goto H; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Nakagawa M
Am J Hematol; 1994 Mar; 45(3):262-4. PubMed ID: 8296801
[TBL] [Abstract][Full Text] [Related]
6. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
[TBL] [Abstract][Full Text] [Related]
7. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
Iino M; Nakajima A; Shindo H
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
[TBL] [Abstract][Full Text] [Related]
8. [Plasma cell leukemia: our experience in 4 cases].
Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
[TBL] [Abstract][Full Text] [Related]
9. [Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)].
Masaki Y; Shimizu S; Takeshita S; Fukutoku M; Yoshioka R; Arai T; Hirose Y; Sugai S; Konda S; Takiguti T
Rinsho Ketsueki; 1994 Jun; 35(6):562-8. PubMed ID: 8078191
[TBL] [Abstract][Full Text] [Related]
10. Plasma cell leukemia--report on two cases.
Singh VP; Sundar S; Kumar K; Shukla J; Dube B
J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
[No Abstract] [Full Text] [Related]
11. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
12. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
[No Abstract] [Full Text] [Related]
13. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
[TBL] [Abstract][Full Text] [Related]
14. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
Libby E; Candelaria-Quintana D; Moualla H; Abdul-Jaleel M; Rabinowitz I
Am J Hematol; 2010 Sep; 85(9):733-4. PubMed ID: 20669178
[No Abstract] [Full Text] [Related]
15. Complete remission in plasma cell leukaemia.
Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
[No Abstract] [Full Text] [Related]
16. [Multiple myeloma of the IgD-lambda type invading CNS].
Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
[TBL] [Abstract][Full Text] [Related]
17. [Nonproducing myeloma without evident bone lesion].
Kawatani T; Maeda N; Hosoda A; Agou H; Nakai K; Kawasaki H
Rinsho Ketsueki; 1990 Jun; 31(6):842-6. PubMed ID: 2214175
[TBL] [Abstract][Full Text] [Related]
18. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy].
Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y
Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176
[TBL] [Abstract][Full Text] [Related]
19. [A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
Ando S; Ando S; Otani N; Kanbe T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):153-6. PubMed ID: 8422181
[TBL] [Abstract][Full Text] [Related]
20. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
